CMI
68
-5
A
40
-3
AIZ
76
13
ADI
70
-6
CVX
26
3
DRI
61
5
ES
47
-3
CNP
59
4
BEN
53
3
BXP
38
-4
AFL
46
4
ADSK
56
-2
CVS
33
-2
CRM
52
2
DHR
62
-2
BK
66
-2
ADBE
56
4
EIX
56
2
APH
43
-3
CMG
56
6
CMI
68
-5
A
40
-3
AIZ
76
13
ADI
70
-6
CVX
26
3
DRI
61
5
ES
47
-3
CNP
59
4
BEN
53
3
BXP
38
-4
AFL
46
4
ADSK
56
-2
CVS
33
-2
CRM
52
2
DHR
62
-2
BK
66
-2
ADBE
56
4
EIX
56
2
APH
43
-3
CMG
56
6
Financhill
Back

SPDR Portfolio Developed World ex-US ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
64

SPDW
SPDR Portfolio Developed World ex-US ETF

Last Price:
$44.21
Seasonality Move:
-0.85%
Buy
65

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.83
Seasonality Move:
-9.01%
Buy
64
SPDR Portfolio Developed World ex-US ETF (SPDW) is a Buy

Is SPDR Portfolio Developed World ex-US ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Developed World ex-US ETF [SPDW] share price is $44.23. The Score for SPDW is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPDW Stock Price Chart

What is SPDR Portfolio Developed World ex-US ETF's stock price today?

  • The SPDR Portfolio Developed World ex-US ETF share price today is $44.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPDW is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.53 Buy
Relative Strength Index (14 RSI): 54.56 Buy
Chaikin Money Flow: -3873754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.02 - 44.5) Buy
Bollinger Bands (100): (41.6 - 43.9) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.46 Sell
20-day SMA: 43.81 Buy
50-day SMA: 43.58 Buy
200-day SMA: 40.62 Buy
8-day EMA: 9.83 Buy
20-day EMA: 4.21 Buy
50-day EMA: 1.73 Buy
200-day EMA: 0.44 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

SPDR Portfolio Developed World ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

SPDR Portfolio Developed World ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):